Casey Fowler - Zivo Bioscience VP Devel
| ZIVOWDelisted Stock | USD 0.55 0.07 14.58% |
Insider
Casey Fowler is VP Devel of Zivo Bioscience Warrants
| Phone | 248 452 9866 |
| Web | https://www.zivobioscience.com |
Zivo Bioscience Management Efficiency
The company has return on total asset (ROA) of (1.6474) % which means that it has lost $1.6474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (39.5602) %, meaning that it generated substantial loss on money invested by shareholders. Zivo Bioscience's management efficiency ratios could be used to measure how well Zivo Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | INSIDER Age | ||
| Mark Newman | GeoVax Labs | 69 | |
| Farrah Dean | BriaCell Therapeutics Corp | N/A | |
| Christopher Bunka | Lexaria Bioscience Corp | 62 | |
| John Docherty | Lexaria Bioscience Corp | 55 | |
| Harriet Robinson | GeoVax Labs | 86 | |
| FACP MD | BriaCell Therapeutics Corp | 78 | |
| CPA CPA | GeoVax Labs | 62 | |
| Vanessa Carle | Lexaria Bioscience Corp | N/A | |
| Philip Ainslie | Lexaria Bioscience Corp | N/A | |
Management Performance
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 |
Zivo Bioscience Warrants Leadership Team
Elected by the shareholders, the Zivo Bioscience's board of directors comprises two types of representatives: Zivo Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zivo. The board's role is to monitor Zivo Bioscience's management team and ensure that shareholders' interests are well served. Zivo Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zivo Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Casey Fowler, VP Devel | ||
| John Payne, CEO President | ||
| David Lafond, VP Technology | ||
| Harlan III, Vice Supply | ||
| Keith Marchiando, Treasurer CFO | ||
| Andrew Dahl, CEO Pres | ||
| Scott Freeman, Chief Officer |
Zivo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zivo Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 | ||||
| Operating Margin | (133.25) % | ||||
| Number Of Shares Shorted | 5.63 K | ||||
| EBITDA | (8.73 M) | ||||
| Net Income | (8.75 M) | ||||
| Total Debt | 445.18 K | ||||
| Cash Flow From Operations | (7.1 M) | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 35.33 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |